LINC01002 Targets miR-650/FLNA Pathway to Suppress Prostate Cancer Progression. Qian L, Wang Y, Xiong Y, Ren H, et al. Urol Int 2023 Apr 11:1-13. doi: 10.1159/000529947.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qian L, Wang Y, Xiong Y, Ren H, et al. LINC01002 Targets miR-650/FLNA Pathway to Suppress Prostate Cancer Progression. Urol Int 2023 Apr 11:1-13. doi: 10.1159/000529947.
PMID: 37040719